Tumor Suppressor Function of miR-127-3p and miR-376a-3p in Osteosarcoma Cells

MiR-127 inhibits ovarian cancer migration and invasion by up-regulating ITGA6

(2021) Xia LIU et al.   MINERVA MEDICA

miR-127 suppresses gastric cancer cell migration and invasion via targeting Wnt7a

(2019) Linlin Wang et al.   Oncology Letters

MicroRNA-127 inhibits cell proliferation via targeting Kif3b in pancreatic β cells

(2019) Ziyang Shen et al.   Aging-US

A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma

(2019) Congwei Huang et al.   International Journal of Clinical Oncology

Downregulation of miR‑136 promotes the progression of osteosarcoma and is associated with the prognosis of patients with osteosarcoma

(2019) Yanchen Chu et al.   Oncology Letters

miR-376a inhibits the proliferation and invasion of osteosarcoma by targeting FBXO11

(2019) Qiaolong Xu et al.   Human Cell

MicroRNA-221 promotes cisplatin resistance in osteosarcoma cells by targeting PPP2R2A

(2019) Wen-chao Yu et al.   BIOSCIENCE REPORTS

microRNA-211 regulates cell proliferation, apoptosis and migration/invasion in human osteosarcoma via targeting EZRIN

(2019) Yihua Pei et al.   CELLULAR & MOLECULAR BIOLOGY LETTERS

miR‑185 regulates the growth of osteosarcoma cells via targeting Hexokinase 2

(2019) Chaojian Liu et al.   Molecular Medicine Reports

Optimization of the chicken chorioallantoic membrane assay as reliable in vivo model for the analysis of osteosarcoma

(2019) Pierre Kunz et al.   PLoS One

MicroRNA‑106b serves as a prognostic biomarker and is associated with cell proliferation, migration, and invasion in osteosarcoma

(2019) Ke Xu et al.   Oncology Letters

MiR-193a regulates chemoresistance of human osteosarcoma cells via repression of IRS2

(2019) Haiyan Wang et al.   Journal of Bone Oncology

MiR-127-3p inhibits cell growth and invasiveness by targeting ITGA6 in human osteosarcoma

(2018) Dong Wang et al.   IUBMB LIFE

MicroRNA‑376a regulates cell proliferation and apoptosis by targeting forkhead box protein P2 in lymphoma

(2018) Shuna Yao et al.   Oncology Letters

miR-376a inhibits breast cancer cell progression by targeting neuropilin-1 NR

(2018) Lansheng Zhang et al.   OncoTargets and Therapy

NRP1-positive lung cancer cells possess tumor-initiating properties

(2017) Luis Jimenez-Hernandez et al.   ONCOLOGY REPORTS

Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness

(2017) Massimo Moro et al.   Scientific Reports

Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine

(2017) Chiranjib Chakraborty et al.   Molecular Therapy-Nucleic Acids

MicroRNA-127-3p inhibits proliferation and invasion by targeting SETD8 in human osteosarcoma cells

(2016) Jun Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Restoration of miR-127-3p and miR-376a-3p counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells by targeting COA1, GLE1 and PDIA6

(2016) Jörg Fellenberg et al.   CANCER LETTERS

MicroRNA-127 is a tumor suppressor in human esophageal squamous cell carcinoma through the regulation of oncogene FMNL3

(2016) Xuhui Gao et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models

(2016) Danielle L. Peacock Brooks et al.   Molecular Cancer

MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene

(2016) Linlin Bi et al.   ONCOLOGY REPORTS

MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer

(2016) Yuan Yu et al.   TUMOR BIOLOGY

The emerging role of lysine methyltransferase SETD8 in human diseases

(2016) Ciro Milite et al.   Clinical Epigenetics

A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis

(2016) Xuetian Yue et al.   Cell Discovery

In vivo delivery of miRNAs for cancer therapy: Challenges and strategies

(2015) Yunching Chen et al.   ADVANCED DRUG DELIVERY REVIEWS

MiR-376a and Histone Deacetylation 9 Form A Regulatory Circuitry in Hepatocellular Carcinoma

(2015) Yongxia Zheng et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

(2015) Stefan S. Bielack et al.   JOURNAL OF CLINICAL ONCOLOGY

Epigenetic silencing of genes and microRNAs within the imprinted Dlk1-Dio3 region at human chromosome 14.32 in giant cell tumor of bone

(2014) Burkhard Lehner et al.   BMC CANCER

MicroRNAs: master regulators of drug resistance, stemness, and metastasis

(2014) Umar Raza et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Therapeutic targeting of microRNAs: current status and future challenges

(2014) Zhonghan Li et al.   NATURE REVIEWS DRUG DISCOVERY

MicroRNA-33b Suppresses Migration and Invasion by Targeting c-Myc in Osteosarcoma Cells

(2014) Ning Xu et al.   PLoS One

Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis

(2013) Anja Bruchmann et al.   BMC CANCER

MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1

(2013) Fang Ji et al.   BONE

Osteosarcoma treatment – Where do we stand? A state of the art review

(2013) Anja Luetke et al.   CANCER TREATMENT REVIEWS

A microRNA signature differentiates between giant cell tumor derived neoplastic stromal cells and mesenchymal stem cells

(2012) Joerg Fellenberg et al.   CANCER LETTERS

Identification of imprinting regulators at the Meg3 differentially methylated region

(2012) Erin N. McMurray et al.   GENOMICS

MicroRNAs in Cancer

(2009) Ramiro Garzon et al.   Annual Review of Medicine

Osteosarcoma incidence and survival rates from 1973 to 2004

(2009) Lisa Mirabello et al.   CANCER